SEC Form 13F
| Report period | 2025-12-31 |
|---|---|
| Publicly available | 2026-02-18 |
| Reported value | $874,680,144 |
| Positions | 27 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| CHARLES RIV LABS INTL INC | CRL | COM | $75,748,141 | 379,728 |
| INTUITIVE SURGICAL INC | ISRG | COM NEW | $53,497,799 | 94,459 |
| REPLIGEN CORP | RGEN | COM | $52,512,870 | 320,474 |
| JAZZ PHARMACEUTICALS PLC | JAZZ | SHS USD | $49,668,900 | 292,170 |
| VERACYTE INC | VCYT | COM | $41,274,461 | 980,391 |
| BOSTON SCIENTIFIC CORP | BSX | COM | $40,120,706 | 420,773 |
| WATERS CORP | WAT | COM | $39,945,582 | 105,167 |
| BROOKDALE SR LIVING INC | BKD | COM | $37,675,044 | 3,491,663 |
| ELI LILLY & CO | LLY | COM | $37,662,161 | 35,045 |
| BRUKER CORP | BRKR | COM | $37,423,242 | 794,380 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.